Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial.
Nassuuna, J; ZIRIMENYA, L; NKURUNUNGI, G; Natukunda, A; Zziwa, C; Ninsiima, C; Apule, B; Onen, C; Amongi, S; Serubanja, J; Tumwesige, P; Nsubuga, D; Amongin, R; Van Dam, GJ; Corstjens, PL A M; Kayiwa, J; Kabagenyi, J; COSE, S; WAJJA, A; KALEEBU, P; WEBB, EL; ELLIOTT, AM; POPVAC trial team,;
2024
The Lancet Global health, (2024).12 11 10.1016/S2214-109X(24)00282-1.
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Chang, VK; Imperial, MZ; Phillips, PP J; Velásquez, GE; Nahid, P; Vernon, A; Kurbatova, EV; Swindells, S; Chaisson, RE; Dorman, SE; Johnson, JL; Weiner, M; Jindani, A; Harrison, T; Sizemore, EE; Whitworth, W; Carr, W; Bryant, KE; Burton, D; Dooley, KE; Engle, M; Nsubuga, P; Diacon, AH; Nhung, NV; Dawson, R; ... Tuberculosis Trials Consortium,
2024
Nature communications, (2024).15 1 10.1038/s41467-024-53273-7.
Cost and cost-effectiveness of digital technologies for support of tuberculosis treatment adherence: a systematic review.
Kafie, C; Mohamed, MS; Zary, M; Chilala, CI; Bahukudumbi, S; Gore, G; Foster, N; FIELDING, KL; Subbaraman, R; Schwartzman, K;
2024
BMJ global health, (2024).9 10 10.1136/bmjgh-2024-015654.
HIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983-2015.
Atkinson, A; Kraus, D; Banholzer, N; Miro, JM; Reiss, P; Kirk, O; Mussini, C; Morlat, P; Podlekareva, D; GRANT, AD; Sabin, C; Van der Valk, M; Le Moing, V; Meyer, L; Seng, R; Castagna, A; Obel, N; Antoniadou, A; Salmon, D; Zwahlen, M; Egger, M; De Wit, S; Furrer, H; Fenner, L; Opportunistic Infections Project Working Group of ,;
2024
PloS one, (2024).19 10 10.1371/journal.pone.0312035.
Africa Health Research Institute (AHRI) Household Contact study: a study protocol, statistical analysis and modelling plan.
KHAN, PY; GOVENDER, I; MCCREESH, N; SWEENEY, S; Sithole, M; Ording-Jespersen, G; Buthelezi, X; HOUBEN, RM G J; BAISLEY, K; Smit, T; Wong, EB; Hanekom, W; WHITE, RG; Vassall, A; FIELDING, K; GRANT, AD;
2024
Wellcome open research, (2024).9, 10.12688/wellcomeopenres.22974.1.
An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates.
PHELAN, J; Van den Heede, K; Masyn, S; Verbeeck, R; CLARK, TG; Lamprecht, DA; KOUL, A; WALL, RJ;
2024
Scientific reports, (2024).14 1 10.1038/s41598-024-75818-y.
Nutritional supplementation for tuberculosis prevention: the RATIONS trial.
Busang, J; KHAN, P;
2024
Lancet (London, England), (2024).404 10462 10.1016/S0140-6736(24)02092-0.
Schistosome and malaria exposure and urban-rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trials.
Natukunda, A; NKURUNUNGI, G; ZIRIMENYA, L; Nassuuna, J; Zziwa, C; Ninsiima, C; Tumusiime, J; Nyanzi, R; Namutebi, M; Kiwudhu, F; Van Dam, GJ; Corstjens, PL A M; Kizindo, R; Nkangi, R; Kabagenyi, J; Nassanga, B; COSE, S; WAJJA, A; KALEEBU, P; ELLIOTT, AM; WEBB, EL; POPVAC trial team,;
2024
The Lancet Global Health, (2024).12 11 10.1016/S2214-109X(24)00340-1.
The effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B): a double-blind, randomised controlled trial.
ZIRIMENYA, L; Natukunda, A; Nassuuna, J; NKURUNUNGI, G; Zziwa, C; Ninsiima, C; Kukundakwe, C; Nankabirwa, CM; Katushabe, C; Namusobya, LK; Oduru, G; Kabami, G; Kabali, J; Kayiwa, J; Kabagenyi, J; Van Dam, GJ; Corstjens, PL A M; COSE, S; WAJJA, A; Staedke, SG; KALEEBU, P; ELLIOTT, AM; WEBB, EL; POPVAC trial team,;
2024
The Lancet Global health, (2024).12 11 10.1016/S2214-109X(24)00281-X.
Systematic review of the economic impact of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection compared with tuberculin skin test and interferon-gamma release assays.
GOSCE, L; Allel, K; Hamada, Y; Surkova, E; Kontsevaya, I; Wang, TT; Liu, W-H; Matveev, A; Ziganshina, LE; Korobitsyn, A; Ismail, N; Bashir, S; Denkinger, CM; Abubakar, I; White, PJ; Rangaka, MX;
2024
PLOS global public health, (2024).4 10 10.1371/journal.pgph.0003655.